Benefits of hormone replacement therapy in postmenopausal women

被引:67
作者
Canderelli, Richard [1 ]
Leccesse, Lisa A.
Miller, Nancy L.
机构
[1] Mem Reg Hosp, Hollywood, FL 33021 USA
[2] Florida Int Univ, Coll Nursing & Hlth Sci, Miami, FL 33199 USA
来源
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS | 2007年 / 19卷 / 12期
关键词
hormone replacement therapy; osteoporosis; hot flashes; cardiovascular; bone mineral density;
D O I
10.1111/j.1745-7599.2007.00269.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: To provide an overview of current research regarding hormone replacement therapy (HRT) and to assist healthcare providers to better educate patients about potential benefits of this therapy. Data sources: A systematic review of healthcare literature was conducted with 602 articles selected from CINAHL, Medscape, Pubmed, and Medline databases. Keywords directing the search included hormone replacement therapy, benefits of hormone replacement therapy and trends, hormone replacement therapy and osteoporosis, hormone replacement, and menopause symptoms. Conclusions: According to the literature, HRT can assist women with postmenopausal symptoms. In addition, research shows that HRT can help some postmenopausal women with selected comorbid conditions such as osteoporosis, type II diabetes, certain cardiovascular pathologies, and colorectal cancer. The decision as to who should use any form of HRT needs to be based on the individual woman's needs, quality of life, and potential risks versus benefits. Implications for practice: HRT has been a benefit to many women in the treatment of postmenopausal symptoms. Recent studies have shown that HRT, whether it is combined estrogen and progestin therapy, or estrogen-only therapy, can help postmenopausal women with osteoporosis and some selected comorbid conditions. Recent research indicates that some women are dying from comorbid conditions rather than breast cancer. Although the research regarding HRT in some areas may be limited, further research adds to existing knowledge and offers new ideas and possibilities in the treatment of postmenopausal symptoms and selected comorbid conditions. Certainly HRT can improve quality of life and possibly longevity for selected women. Ongoing research is needed to further validate such benefits, as well as to further explore the risks and benefits of long-term HRT. Increased knowledge about HRT will help healthcare providers better educate patients about the potential benefits of HRT, while providing documentation about who should take selected types of HRT or whether alternative treatment is preferred.
引用
收藏
页码:635 / 641
页数:7
相关论文
共 20 条
[1]
*AM COLL OBST GYN, 2004, FREQ ASK QUEST HORM
[2]
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures - The Women's Health Initiative randomized trial [J].
Anderson, GL ;
Judd, HL ;
Kaunitz, AM ;
Barad, DH ;
Beresford, SAA ;
Pettinger, M ;
Liu, J ;
McNeeley, SG ;
Lopez, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1739-1748
[3]
Beers M. H., 2005, MERCK MANUAL GERIATR
[4]
Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: Differences associated with years since menopause [J].
Brownley, KA ;
Hinderliter, AL ;
West, SG ;
Grewen, KM ;
Steege, JF ;
Girdler, SS ;
Light, KC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (04) :1052-1058
[5]
Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial [J].
Cauley, JA ;
Robbins, J ;
Chen, Z ;
Cummings, SR ;
Jackson, RD ;
LaCroix, AZ ;
LeBoff, M ;
Lewis, CE ;
McGowan, J ;
Neuner, J ;
Pettinger, M ;
Stefanick, ML ;
Wactawski-Wende, J ;
Watts, NB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1729-1738
[6]
Estrogen plus progestin and colorectal cancer in postmenopausal women [J].
Chlebowski, RT ;
Wactawski-Wende, J ;
Ritenbaugh, C ;
Hubbell, FA ;
Ascensao, J ;
Rodabough, RJ ;
Rosenberg, CA ;
Taylor, VM ;
Harris, R ;
Chen, C ;
Adams-Campbell, LL ;
White, E ;
Alving, B ;
Rossouw, J ;
Pottern, L ;
Ludlam, S ;
McGowan, J ;
Prentice, R ;
Anderson, G ;
LaCroix, A ;
Patterson, R ;
McTiernan, A ;
Cochrane, B ;
Hunt, J ;
Tinker, L ;
Kooperberg, C ;
McIntosh, M ;
Wang, CY ;
Chen, C ;
Bowen, D ;
Kristal, A ;
Stanford, J ;
Urban, N ;
Weiss, N ;
White, E ;
Shumaker, S ;
Rautaharju, P ;
Prineas, R ;
Naughton, M ;
Stein, E ;
Laskarzewski, P ;
Cummings, S ;
Nevitt, M ;
Dockrell, M ;
Harnack, L ;
Cammarata, F ;
Lindenfelser, S ;
Psaty, B ;
Heckbert, S ;
Wassertheil-Smoller, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :991-1004
[7]
Progestins and breast cancer [J].
Eden, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (05) :1123-1131
[8]
Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes - The Northern California Kaiser Permanente Diabetes Registry [J].
Ferrara, A ;
Karter, AJ ;
Ackerson, LM ;
Liu, JY ;
Selby, JV .
DIABETES CARE, 2001, 24 (07) :1144-1150
[9]
Managing menopausal symptoms after the women's health initiative [J].
Hackley, B ;
Rousseau, ME .
JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2004, 49 (02) :87-95
[10]
HALL L, 2000, TAKING CHARGE MENOPA